Printer Friendly

Mixed Titer Performance Panel.

An Anti-Dengue Mixed Titer Performance Panel has recently been launched by SeraCare as its first commercially available line of infectious disease panels responding to the demand for accurate testing for dengue virus. It is designed to help blood donor collection facilities, diagnostics manufacturers, and clinical laboratories evaluate and troubleshoot their anti-dengue virus assays. The new performance panel is derived from undiluted, unpreserved human plasma specimens, with 21 members representing a wide range of reactivity for anti-dengue IgM and IgG antibodies, from negative to strongly positive. Panel members include samples from individuals with recent and past infection by all four dengue viruses.

SeraCare Life Sciences Visit www.rsleads.com/209m1-155

COPYRIGHT 2012 NP Communications, LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2012 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Blood banking and transfusion
Publication:Medical Laboratory Observer
Article Type:Brief article
Date:Sep 1, 2012
Words:109
Previous Article:Trackable Ergonomic Carrier.
Next Article:Accurate donor screening.
Topics:

Terms of use | Privacy policy | Copyright © 2022 Farlex, Inc. | Feedback | For webmasters |